Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 255

1.

Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.

Wiegell SR, Johansen UB, Wulf HC.

Acta Derm Venereol. 2019 Feb 1;99(2):242-243. doi: 10.2340/00015555-3049. No abstract available.

2.

Evaluation of Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution, 0.025% for Treatment of Ocular Redness.

Torkildsen GL, Sanfilippo CM, DeCory HH, Gomes PJ.

Curr Eye Res. 2018 Jan;43(1):43-51. doi: 10.1080/02713683.2017.1381269. Epub 2017 Nov 9.

PMID:
29120262
3.

Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery.

Chen E, Patel RA, Kwak YJ, Huang CC.

J Am Acad Dermatol. 2017 Dec;77(6):1114-1118. doi: 10.1016/j.jaad.2017.08.022. Epub 2017 Oct 12.

PMID:
29031658
4.

Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.

Gold LS, Papp K, Lynde C, Lain E, Gooderham M, Johnson S, Kerrouche N.

J Drugs Dermatol. 2017 Sep 1;16(9):909-916.

PMID:
28915286
5.

Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component.

Micali G, Dall'Oglio F, Verzì AE, Luppino I, Bhatt K, Lacarrubba F.

Lasers Med Sci. 2018 Aug;33(6):1397-1400. doi: 10.1007/s10103-017-2318-3. Epub 2017 Sep 9.

PMID:
28889348
6.

Sedative and physiological effects of brimonidine tartrate ophthalmic solution in healthy cats.

Ogata N, Kanda T, Kawahata M, Ichikawa T, Matsumoto Y, Morimitsu W, Nishino Y, Itoi T, Furumoto K.

Vet Anaesth Analg. 2017 Sep;44(5):1091-1100. doi: 10.1016/j.vaa.2017.06.005. Epub 2017 Jul 3.

PMID:
28865952
7.

Brimonidine-timolol versus brinzolamide-timolol for treatment of elevated intraocular pressure after phacoemulsification surgery.

Balsak S, Kaydu A, Erdem S, Fuat Alakus M, Ozkurt ZG.

Int Ophthalmol. 2018 Aug;38(4):1583-1589. doi: 10.1007/s10792-017-0626-z. Epub 2017 Jul 3.

PMID:
28674856
8.

Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.

Mizoue S, Nitta K, Shirakashi M, Nitta A, Yamabayashi S, Kimura T, Ueda T, Takeda R, Matsumoto S, Yoshikawa K.

Adv Ther. 2017 Jun;34(6):1438-1448. doi: 10.1007/s12325-017-0552-5. Epub 2017 May 15. Erratum in: Adv Ther. 2017 Aug 30;:.

PMID:
28508306
9.

The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.

Seibold LK, DeWitt PE, Kroehl ME, Kahook MY.

J Ocul Pharmacol Ther. 2017 Apr;33(3):161-169. doi: 10.1089/jop.2016.0141. Epub 2017 Jan 27.

10.

Comparison of dorzolamide/timolol vs brinzolamide/brimonidine fixed combination therapy in the management of primary open-angle glaucoma.

Kozobolis V, Panos GD, Konstantinidis A, Labiris G.

Eur J Ophthalmol. 2017 Mar 10;27(2):160-163. doi: 10.5301/ejo.5000826. Epub 2016 Jul 16.

PMID:
27445072
11.

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.

Fechtner RD, Myers JS, Hubatsch DA, Budenz DL, DuBiner HB.

Eye (Lond). 2016 Oct;30(10):1343-1350. doi: 10.1038/eye.2016.126. Epub 2016 Jul 1.

12.

Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).

Frydkjaer-Olsen U, Soegaard Hansen R, Simó R, Cunha-Vaz J, Peto T, Grauslund J; EUROCONDOR.

Ophthalmic Res. 2016;56(1):10-6. doi: 10.1159/000444396. Epub 2016 Apr 8.

13.

A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.

Feldman RM, Katz G, McMenemy M, Hubatsch DA, Realini T.

Am J Ophthalmol. 2016 May;165:188-97. doi: 10.1016/j.ajo.2016.02.026. Epub 2016 Mar 3.

14.

Effect of alpha-2-agonist premedication on intraocular pressure after selective laser trabeculoplasty.

Oatts JT, Wang X, Loewen NA.

Indian J Ophthalmol. 2015 Dec;63(12):891-4. doi: 10.4103/0301-4738.176035.

15.

Argon Laser Peripheral Iridoplasty for Primary Angle-Closure Glaucoma: A Randomized Controlled Trial.

Narayanaswamy A, Baskaran M, Perera SA, Nongpiur ME, Htoon HM, Tun TA, Wong TT, Goh D, Su DH, Chew PT, Ho CL, Aung T.

Ophthalmology. 2016 Mar;123(3):514-21. doi: 10.1016/j.ophtha.2015.11.002. Epub 2015 Dec 23.

PMID:
26707418
16.

Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.

Kim JM, Kim TW, Kim CY, Kim HK, Park KH.

Jpn J Ophthalmol. 2016 Jan;60(1):20-6. doi: 10.1007/s10384-015-0420-2. Epub 2015 Nov 18.

PMID:
26578422
17.

Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study.

Layton AM, Schaller M, Homey B, Hofmann MA, Bewley AP, Lehmann P, Nohlgård C, Sarwer DB, Kerrouche N, Ma YM.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2405-10. doi: 10.1111/jdv.13305. Epub 2015 Sep 28.

18.

Anterior segment morphology after acute primary angle closure treatment: a randomised study comparing iridoplasty and medical therapy.

Sng CC, Aquino MC, Liao J, Zheng C, Ang M, Chew PT.

Br J Ophthalmol. 2016 Apr;100(4):542-8. doi: 10.1136/bjophthalmol-2015-307087. Epub 2015 Aug 20.

PMID:
26294102
19.

Erythema of Rosacea: Validation of Patient's Self-Assessment Grading Scale.

Tan J, Leoni M.

J Drugs Dermatol. 2015 Aug;14(8):841-4.

PMID:
26267728
20.

Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.

Mansouri K, Medeiros FA, Weinreb RN.

Clin Exp Ophthalmol. 2015 Dec;43(9):787-95. doi: 10.1111/ceo.12567. Epub 2015 Aug 16.

Supplemental Content

Loading ...
Support Center